JAMA Psychiatry Publishes Otsuka, Lundbeck PTSD Trial Results
18 Dec 2024 //
BUSINESSWIRE
OPH & Amalgam Rx Announce Digital Support For Alzheimer’s Caregiver
07 Oct 2024 //
BUSINESSWIRE
Otsuka, Lundbeck start ad push for long-acting bipolar drug
05 Jun 2024 //
FIERCE PHARMA
Otsuka backs Bradley Cooper-produced doc film about caregivers
09 May 2024 //
FIERCE PHARMA
SynCrest Launches CRDMO Service for Peptide-based Therapeutics
12 May 2023 //
CONTRACT PHARMA
Sunovion and Otsuka Initiate Clinical Development of Ulotaront
26 Apr 2023 //
BUSINESSWIRE
Schrödinger expands neuroscience work with BMS, Otsuka deals
09 Jan 2023 //
FIERCE BIOTECH
Otsuka to Launch AJOVY Subcutaneous Injection 225 mg Syringe in Japan
30 Aug 2021 //
PRESS RELEASE
Busulfex Injection 60mg Approved in Japan for Once-daily Administration
25 Aug 2021 //
THEPHARMALETTER
MSN labs to launch two new generics in USA
06 Sep 2019 //
THEPHARMALETTER
Otsuka scores PhIII win for another Astex drug; GSK expands Nucala use in asthma
07 Jun 2019 //
ENDPTS
Otsuka Chemical acquires Cefixime business of Astellas Pharma
06 Jun 2019 //
BIOSPECTRUM
Lundbeck’s Dunsire has something to cheer as Rexulti combo shows promise in PTSD
30 Nov 2018 //
ENDPTS
Otsuka Pharmaceutical Development & Commercialization Hosts Roundtable
16 Nov 2018 //
PR NEWSWIRE
AMITIZA® (lubiprostone) : Sucampo Pharmaceuticals vs. Sun Pharmaceutical
31 Oct 2018 //
PATENT LITIGATION
Enforcement Report - Week of October 10, 2018
10 Oct 2018 //
FDA
Woman Sues Abilify Marketers Over Hefty Gambling Losses
02 Aug 2018 //
BIOSPACE
EC approves extension of indication for Otsuka’s tolvaptan for CKD
02 Aug 2018 //
BUSINESSWIRE
FiercePharmaAsia—Biogen-Eisai, Otsuka, Samsung and more
13 Jul 2018 //
FIERCE PHARMA
Otsuka to acquire antibody developer Visterra in $430M deal
12 Jul 2018 //
FIERCE BIOTECH
Envision Pharma Group announces support Otsuka’s medical affairs activities.
11 Jul 2018 //
PHARMA FILE
Otsuka Announces Ph3 Results for Tolvaptan in Patients with Autosomal Disease
06 Nov 2017 //
BUSINESSWIRE
Bayer`s hefty 2016 growth underlines danger of neglecting R&D for Monsanto
22 Feb 2017 //
FIERCE PHARMA
Japanese Companies Make Cautious Return to Indian Pharma Market
04 Jan 2017 //
ECONOMIC TIMES
Acucela`s founder wrests back the reins after proxy battle
04 May 2015 //
FIERCE BIOTECH
Judge Tosses Abilify Kickback Claims, But Puts BMS On Notice For Firing Whistleblowers
01 Apr 2015 //
FIERCE PHARMA
FDA Lets Lilly`s Long-Acting Zyprexa Off The Hook In Patient Deaths
25 Mar 2015 //
FIERCE PHARMA
Pharma Sector May Lose $65 Bn by 2019: Analyst
10 Dec 2014 //
BIOSPECTRUMASIA
Abilify Maintena Kit Approval
05 Dec 2014 //
LUNDBECK WEBSITE